Aducanumab and ARIA: Does the FDA’s Prescribing Label Fall Short?

As aducanumab begins its integration into clinical practice, some physicians are concerned the drug's prescribing label does not include adequate brain imaging recommendations to detect ARIA in a timely way.
Medscape Medical News
As aducanumab begins its integration into clinical practice, some physicians are concerned the drug’s prescribing label does not include adequate brain imaging recommendations to detect ARIA in a timely way.
Medscape Medical News